The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
761
March 11, 1988
View Complete Issue         Table of Contents 2019 
Alpha1-Proteinase Inhibitor for Alpha1-Antitrypsin Deficiency
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Alpha1-Proteinase Inhibitor for Alpha1-Antitrypsin Deficiency
March 11, 1988 (Issue: 761)
Human alpha1-proteinase inhibitor (Prolastin Cutter), possibly better known as alpha1-antitypsin (ATT), is now available in the USA for replacement therapy in patients with emphysema who have a congential deficiency of the protein.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Alpha1-Proteinase Inhibitor for Alpha1-Antitrypsin Deficiency
Article code: 761a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.